Skip to main content
. 2019 Nov 13;31(1):1–12. doi: 10.1007/s00198-019-05176-3

Fig. 3.

Fig. 3

Treatment pathways according to the categorisation of fracture risk. For treatment modalities (inhibitors of bone resorption, anabolic agents, etc.), see Appendix, Table 6